Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 50 /hr
Hire Dr. Dheeraj S.
Switzerland
USD 50 /hr
Research Scientist/ Medical Writing/ Consulting/ Drug Screening/ Oncology/ Scientific Advisor/ Medical Reviewer
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing,
Copywriting,
Newswriting
Research
Market Research,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Healthcare Consulting,
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Image Analysis,
Data Visualization,
Big Data Analytics
Work Experience
Medical writing, Science editor (freelancer), Research Consultant,
Freelancing
May 2021 - Present
Biologist/Research Scientist
Institute of Oncology Research, Bellinzona, Switzerland
January 2018 - April 2021
Research Assistant - Research Associate
Institute of Oncology Research, Bellinzona, Switzerland
October 2014 - December 2017
Education
Doctor of Philosophy (Ph.D)
Zurich University, Switzerland
February 2010 - September 2014
Ph.D (Cancer Research)
University of Zurich
2010 - 2014 
Masters (Molecular Biology)
University of Skövde
2008 - 2010
Masters (Molecular Biology)
Skovde University, Sweden
January 2008 - September 2009
Bachelor in Pharmacy
Shivaji University
July 2003 - July 2007
Certifications
Publications
JOURNAL ARTICLE
Dheeraj Shinde, Gurparsad Singh Suri, Gurleen Kaur (2024). Beyond boundaries: exploring the transformative power of AI in pharmaceuticals . Discover Artificial Intelligence.
Dheeraj Shinde, Alessia Cacciatore, Carola Musumeci, Giada Sandrini, Luca Guarrera, Domenico Albino, Gianluca Civenni, Elisa Storelli, Simone Mosole, Elisa Federici, et al. (2024). Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer . Nature Communications.
Dheeraj Shinde, Gurleen Kaur, Gurparsad Singh Suri (2023). Investigating Torsin‐1A‐interacting protein 1 as a predictive and immunological biomarker in cancer . iLABMED.
Dheeraj Shinde, Gurparsad Singh Suri, Gurleen Kaur, Giuseppina M. Carbone (2023). Metabolomics in oncology . Cancer Reports.
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer <head>
<META HTTP-EQUIV="Refresh" CONTENT="0;URL=/servlet/useragent">
</head> . Nature Communications.
Hyrije Ademi and Dheeraj A. Shinde and Max Gassmann and Daniela Gerst and Hassan Chaachouay and Johannes Vogel and Thomas A. Gorr(2021). Targeting neovascularization and respiration of tumor grafts grown on chick embryo chorioallantoic membranes . PLOS ONE. 16. (5). p. e0251765. Public Library of Science ({PLoS})
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer <head>
<META HTTP-EQUIV="Refresh" CONTENT="0;URL=/servlet/useragent">
</head> . Communications Biology.
Albino, D., Falcione, M., Uboldi, V., Temilola, D.O., Sandrini, G., Merulla, J., Civenni, G., Kokanovic, A., Stürchler, A., Shinde, D., et al.(2021). Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer . Communications Biology. 4. (1).
Mapelli, S.N., Albino, D., Mello-Grand, M., Shinde, D., Scimeca, M., Bonfiglio, R., Bonanno, E., Chiorino, G., Garcia-Escudero, R., Catapano, C.V., et al.(2020). Erratum: Mapelli, S.N., et al. a novel prostate cell type-specific gene signature to interrogate prostate tumor differentiation status and monitor therapeutic response (running title: Phenotypic classification of prostate tumors). (Cancers 2020, 12, 176) . Cancers. 12. (10). p. 1-2.
Mapelli, S.N., Albino, D., Mello-Grand, M., Shinde, D., Scimeca, M., Bonfiglio, R., Bonanno, E., Chiorino, G., Garcia-Escudero, R., Catapano, C.V., et al.(2020). A novel prostate cell type-specific gene signature to interrogate prostate tumor differentiation status and monitor therapeutic response (Running title: Phenotypic classification of prostate tumors) . Cancers. 12. (1).
Gianluca Civenni and Domenico Albino and Dheeraj Shinde and Ramiro V{\'{a}}zquez and Jessica Merulla and Aleksandra Kokanovic and Sarah N. Mapelli and Giuseppina M. Carbone and Carlo V. Catapano(2019). Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells . Frontiers in Oncology. 9. Frontiers Media {SA}
D. Albino and M. Falcione and D.S. Shinde and G. Civenni and J. Merulla and C.V. Catapano and G.M. Carbone(2019). miR-424 secreted in extracellular vesicles/exosomes promotes prostate tumorigenesis . European Urology Supplements. 18. (1). p. e70. Elsevier {BV}
G.M. Carbone and D. Albino and D. Shinde and M. Zoma and A. Zoma and A. Kokanovic and G. Civenni and C.V. Catapano(2019). The tumor suppressor ESE3/EHF acts as a gatekeeper in TMPRSS2-ERG positive tumors . European Urology Supplements. 18. (1). p. e346. Elsevier {BV}
Vázquez, R., Civenni, G., Kokanovic, A., Shinde, D., Cantergiani, J., Marchetti, M., Zoppi, G., Ruggeri, B., Liu, P.C.C., Carbone, G.M., et al.(2019). Efficacy of Novel Bromodomain and Extraterminal Inhibitors in Combination with Chemotherapy for Castration-Resistant Prostate Cancer . European Urology Oncology.
Shinde, D., Albino, D., Zoma, M., Mutti, A., Mapelli, S.N., Civenni, G., Kokanovic, A., Merulla, J., Perez-Escuredo, J., Costales, P., et al.(2019). Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer . European Urology Oncology. 2. (4). p. 415-424.
Civenni, G., Albino, D., Shinde, D., Vázquez, R., Merulla, J., Kokanovic, A., Mapelli, S.N., Carbone, G.M., Catapano, C.V.(2019). Transcriptional reprogramming and novel therapeutic approaches for targeting prostate cancer stem cells . Frontiers in Oncology. 9. (MAY).
D. Albino and D. Shinde and M. Zoma and S.N. Mapelli and A. Kokanovic and S. Mosole and P. Costales and G. Civenni and F. Moris and C.V. Catapano and G.M. Carbone(2018). Therapeutic reprogramming of the transcriptome of ERG-positive prostate cancers by epigenetic and transcriptional modulators . European Urology Supplements. 17. (10). p. e2487. Elsevier {BV}
G. Civenni and D. Shinde and M. Zoma and D. Albino and P. Costales and F. Moris and G. Carbone and C. Catapano(2017). The multi-kinase inhibitor EC-70124 delivers a double-hit to prostate cancer stem cells interfering with both STAT3 and NF-kB signaling . European Urology Supplements. 16. (3). p. e1294. Elsevier {BV}
Lissat, A., Joerschke, M., Shinde, D.A., Braunschweig, T., Meier, A., Makowska, A., Bortnick, R., Henneke, P., Herget, G., Gorr, T.A., et al.(2015). IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells . BMC Cancer. 15. (1).
Hu, J., Stiehl, D.P., Setzer, C., Wichmann, D., Shinde, D.A., Rehrauer, H., Hradecky, P., Gassmann, M., Gorr, T.A.(2011). Interaction of HIF and USF signaling pathways in human genes flanked by hypoxia-response elements and E-box palindromes . Molecular Cancer Research. 9. (11). p. 1520-1536.
CONFERENCE ABSTRACT
Ramiro V{\'{a}}zquez and Gianluca Civenni and Giada Zoppi and Dheeraj Shinde and Aleksandra Kokanovic and Phillip Liu and Bruce Ruggeri and Giuseppina M. Carbone and Carlo V. Catapano(2018). Abstract 5793: Anti-tumor efficacy of INCB057643, a novel BET bromodomain inhibitor, in castration-resistant prostate cancer as single agent and in combination therapy . Experimental and Molecular Therapeutics. American Association for Cancer Research
Marita Zoma and Dheeraj Shinde and Domenico Albino and Simone Mosole and Jacopo Sgrignani and Andrea Cavalli and Carlo V. Catapano and Giuseppina M. Carbone(2018). Abstract LB-201: ERG lysine methylation promotes prostate cancer progression in ERG transgenic mice . Molecular and Cellular Biology / Genetics. American Association for Cancer Research
Giuseppina M. R. Carbone and Laura Curti and Marita Zoma and Abhishek Mitra and Dheeraj Shinde and Domenico Albino and Simona Rossi and Gianluca Civenni and George N. Thalmann and Giovanna Chiorino and Carlo Catapano(2016). Abstract LB-152: EZH2-induced lysine methylation and ERG-EZH2 genomic co-occupancy set the basis for extensive transcriptome reprogramming and prostate cancer progression . Molecular and Cellular Biology, Genetics. American Association for Cancer Research
Ratings and Comments
Total Projects Awarded:
Comments: